VANCOUVER, British Columbia, Sept. 28, 2022 BYND Cannasoft Enterprises Inc. announced that its subsidiary BYND - Beyond Solutions Ltd. has signed an agreement with the Weizmann Institute of. | September 28, 2022
/PRNewswire/ Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing treatments for ALS and diabetes, has been granted its third.